| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.6% | |
| Div Cover | 5.7 | |
| Op Mrgn | 26.4% | |
| ROCE | 25.4% |
| Latest | F'cast | |
|---|---|---|
| P/E | 30.0 | |
| PEG | 0.6 | |
| Pr/Revenue | 6.3 | |
| Pr/Book | 4.3 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 31.6% | |
| PBT | n/a | |
| EPS | 46.2% | |
| DPS | 4.3% |
| Year Ending | Revenue ( m) | Pre-tax ( m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-21 | 5,777.00 | 1,226.00 | 560.00¢ | 17.9 | 0.4 | +45% | 130.00¢ | 1.3% |
| 31-Dec-22 | 5,517.00 | 511.00 | 221.00¢ | 33.3 | n/a | -60% | 133.00¢ | 1.8% |
| 31-Dec-23 | 4,867.00 | 441.00 | 181.00¢ | 43.6 | n/a | -18% | 136.00¢ | 1.7% |
| 31-Dec-24 | 5,613.00 | 1,163.00 | 561.00¢ | 34.3 | 0.2 | +210% | 139.00¢ | 0.7% |
| 31-Dec-25 | 7,388.00 | 1,163.00 | 820.00¢ | 29.1 | 0.6 | +46% | 145.00¢ | 0.6% |
| Year Ending | Revenue ( m) | Pre-tax ( m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-26 | 8,690.85 | 2,457.06 | 1,137.92¢ | 18.3 | 0.5 | +39% | 143.93¢ | 0.0% |
| 31-Dec-27 | 9,674.49 | 2,942.10 | 1,346.19¢ | 15.5 | 0.8 | +18% | 148.27¢ | 0.0% |
Copyright © 2026 FactSet Research Systems Inc. All rights reserved.
| Belgium's UCB to buy US-based Ra Pharmaceuticals... | 10-Oct-2019 | ShareCast |
| GSK gets emerging markets boost with UCB deal | 24-Jan-2009 | Telegraph |
| UCB confident on drug go-ahead | 21-Aug-2007 | The Scotsman |
| Fellner shuffles Acambis board | 08-Mar-2007 | Telegraph |
| Currency | Euro |
| Share Price | 212.10 |
| Change Today | 4.00 |
| % Change | 1.92 % |
| 52 Week High | 275.00 |
| 52 Week Low | 196.50 |
| Volume | 213,832 |
| Shares Issued | 190.00m |
| Market Cap | 40,299m |
| Beta | 0.01 |
| Strong Buy | 7 |
| Buy | 6 |
| Neutral | 4 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 17 |

| Time | Volume / Share Price |
| 17:35 | 200 @ 212.10 |
| 17:35 | 387 @ 212.10 |
| 17:35 | 194 @ 212.10 |
| 17:35 | 134 @ 212.10 |
| 17:35 | 60 @ 212.10 |
You are here: research